Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development

Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry has been selected as the winner of the API Development Award, presented at the CPhI Pharma Awards in Barcelona, Spain. The annual award is presented to a company that demonstrates innovation in technologies, products, processes and services for the development […]

thaipr.net

25 ต.ค. 66

Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina

Cambrex today announced the completion of its $38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. This expansion doubles the facility’s manufacturing capacity, with new state-of-the-art analytical and chemical development laboratories, two new clinical manufacturing suites, and a small-scale commercial manufacturing operation with three work…

thaipr.net

3 ต.ค. 66

Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, […]

thaipr.net

1 มิ.ย. 66

Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that Snapdragon Chemistry has completed the second phase of its 51,000 square foot expansion in Waltham, Massachusetts. This expansion adds an additional 12,000 square feet to Snapdragon’s active pharmaceutical ingredient […]

thaipr.net

17 พ.ค. 66

Cambrex Opens New Stability Storage Facility in Belgium

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its capacity for environmentally-controlled stability storage services to the pharmaceutical, medical […]

thaipr.net

5 เม.ย. 66

Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year

Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized with 2023 CDMO Leadership Awards in the categories of Quality, Service, Expertise, and Compatibility. Additionally, Cambrex was selected as a “Champion” in the Service category.  This marks the ninth consecutive year Cambrex has been acknowledged with an award. […]

thaipr.net

2 มี.ค. 66

Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. “Today, we […]

thaipr.net

19 ม.ค. 66

Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services

Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma […]

thaipr.net

22 พ.ย. 65

Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa

Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis–St. Paul Airport, the new facility will specialize in analytical and chemical development for pharmaceutical drug candidates and will operate as an extension of Cambrex’s […]

thaipr.net

28 ต.ค. 65

Cambrex Completes Large-Scale US API Expansion

Cambrex announced today the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility. The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex’s flagship API facility by 30%. The […]

thaipr.net

18 เม.ย. 65
1 2